non small lung cancer trang 15 tải miễn phí từ TAILIEUCHUNG

"non small lung cancer" trang 15 - tải miễn phí từ Tailieuchung

A retrospective study of alectinib versus ceritinib in patients with advanced non– small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

A retrospective study of alectinib versus ceritinib in patients with advanced non– small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

8 44 1

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

6 35 1

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer

7 22 1

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

11 10 1

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelialmesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelialmesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2

10 17 1

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

11 15 1

Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: A case report and review of the literature

Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: A case report and review of the literature

9 23 1

Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer

Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer

9 24 1

Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: A retrospective analysis from the I-O Optimise initiative

Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: A retrospective analysis from the I-O Optimise initiative

13 39 1

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

5 27 1

LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival

LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival

6 6 1

Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: A meta-analysis and system review

Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: A meta-analysis and system review

8 12 1

Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer

Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer

9 30 1

Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

8 26 1

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

11 20 1

LncRNA DLGAP1-AS2 regulates miR-503/ cyclin D1 to promote cell proliferation in non-small cell lung cancer

LncRNA DLGAP1-AS2 regulates miR-503/ cyclin D1 to promote cell proliferation in non-small cell lung cancer

8 40 1

Surgical therapy for early stage non small cell lung cancer: VATS versus Thoracotomy

Surgical therapy for early stage non small cell lung cancer: VATS versus Thoracotomy

7 21 1

Detection of EGFR mutation and its association with clinicopathological features of non-small cell lung cancer patients

Detection of EGFR mutation and its association with clinicopathological features of non-small cell lung cancer patients

5 6 1

Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis

Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis

14 2 1

Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion

Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion

10 58 0

Đầu
1
2
3
4
5
6
7
8
9
10
11
12
13
14
[ 15 ]
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.